BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 22863678)

  • 1. Sex differences in U50,488H-induced phosphorylation of p44/42 mitogen-activated protein kinase in the guinea pig brain.
    Rasakham K; McGillivray KL; Liu-Chen LY
    Neuroscience; 2012 Oct; 223():447-56. PubMed ID: 22863678
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Sex difference in κ-opioid receptor (KOPR)-mediated behaviors, brain region KOPR level and KOPR-mediated guanosine 5'-O-(3-[35S]thiotriphosphate) binding in the guinea pig.
    Wang YJ; Rasakham K; Huang P; Chudnovskaya D; Cowan A; Liu-Chen LY
    J Pharmacol Exp Ther; 2011 Nov; 339(2):438-50. PubMed ID: 21841040
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Determination of sites of U50,488H-promoted phosphorylation of the mouse κ opioid receptor (KOPR): disconnect between KOPR phosphorylation and internalization.
    Chen C; Chiu YT; Wu W; Huang P; Mann A; Schulz S; Liu-Chen LY
    Biochem J; 2016 Feb; 473(4):497-508. PubMed ID: 26635353
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Molecular basis of differences in (-)(trans)-3,4-dichloro-N-methyl-N-[2-(1-pyrrolidiny)-cyclohexyl]benzeneacetamide-induced desensitization and phosphorylation between human and rat kappa-opioid receptors expressed in Chinese hamster ovary cells.
    Li J; Li JG; Chen C; Zhang F; Liu-Chen LY
    Mol Pharmacol; 2002 Jan; 61(1):73-84. PubMed ID: 11752208
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Agonist-Dependent and -Independent κ Opioid Receptor Phosphorylation: Distinct Phosphorylation Patterns and Different Cellular Outcomes.
    Chiu YT; Chen C; Yu D; Schulz S; Liu-Chen LY
    Mol Pharmacol; 2017 Nov; 92(5):588-600. PubMed ID: 28893975
    [TBL] [Abstract][Full Text] [Related]  

  • 6. U50,488H-induced internalization of the human kappa opioid receptor involves a beta-arrestin- and dynamin-dependent mechanism. Kappa receptor internalization is not required for mitogen-activated protein kinase activation.
    Li JG; Luo LY; Krupnick JG; Benovic JL; Liu-Chen LY
    J Biol Chem; 1999 Apr; 274(17):12087-94. PubMed ID: 10207034
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Differential regulation of the human kappa opioid receptor by agonists: etorphine and levorphanol reduced dynorphin A- and U50,488H-induced internalization and phosphorylation.
    Li JG; Zhang F; Jin XL; Liu-Chen LY
    J Pharmacol Exp Ther; 2003 May; 305(2):531-40. PubMed ID: 12606694
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Behavioural effect of pretreatment with opioid antagonists and sigma binding site ligands on the abnormal motor response produced by the kappa opioid agonist U50,488H in guinea pigs.
    Brent PJ
    Neuropharmacology; 1993 Aug; 32(8):751-60. PubMed ID: 8413839
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of ACEA-1328, a NMDA receptor/glycine site antagonist, on U50,488H-induced antinociception and tolerance.
    Lutfy K; Doan P; Nguyen M; Weber E
    Eur J Pharmacol; 1999 Nov; 384(1):1-5. PubMed ID: 10611412
    [TBL] [Abstract][Full Text] [Related]  

  • 10. (-)U50,488H [(trans)-3,4-dichloro-N-methyl-N-[2-(1-pyrrolidinyl)-cyclohexyl]benzeneacetamide] induces internalization and down-regulation of the human, but not the rat, kappa-opioid receptor: structural basis for the differential regulation.
    Zhang F; Li J; Li JG; Liu-Chen LY
    J Pharmacol Exp Ther; 2002 Sep; 302(3):1184-92. PubMed ID: 12183679
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Agonist-promoted kappa opioid receptor (KOR) phosphorylation has behavioral endpoint-dependent and sex-specific effects.
    Huang P; Chen C; Cao D; Huang M; Liu-Chen LY
    Neuropharmacology; 2022 Jan; 202():108860. PubMed ID: 34736959
    [TBL] [Abstract][Full Text] [Related]  

  • 12. p38 mitogen-activated protein kinase activation in amygdala mediates κ opioid receptor agonist U50,488H-induced conditioned place aversion.
    Zan GY; Wang Q; Wang YJ; Chen JC; Wu X; Yang CH; Chai JR; Li M; Liu Y; Hu XW; Shu XH; Liu JG
    Neuroscience; 2016 Apr; 320():122-8. PubMed ID: 26826330
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Role of protein kinase C-epsilon in the development of kappa-opioid receptor tolerance to U50,488H in rat ventricular myocytes.
    Zhou JJ; Bian JS; Pei JM; Wu S; Li HY; Wong TM
    Br J Pharmacol; 2002 Apr; 135(7):1675-84. PubMed ID: 11934807
    [TBL] [Abstract][Full Text] [Related]  

  • 14. U50,488H inhibits effects of norepinephrine in rat cardiomyocytes-cross-talk between kappa-opioid and beta-adrenergic receptors.
    Yu XC; Li HY; Wang HX; Wong TM
    J Mol Cell Cardiol; 1998 Feb; 30(2):405-13. PubMed ID: 9515017
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mechanisms of agonist-induced down-regulation of the human kappa-opioid receptor: internalization is required for down-regulation.
    Li JG; Benovic JL; Liu-Chen LY
    Mol Pharmacol; 2000 Oct; 58(4):795-801. PubMed ID: 10999950
    [TBL] [Abstract][Full Text] [Related]  

  • 16. U50,488H postconditioning reduces apoptosis after myocardial ischemia and reperfusion.
    Tong G; Sun Z; Wei X; Gu C; Kaye AD; Wang Y; Li J; Zhang Q; Guo H; Yu S; Yi D; Pei J
    Life Sci; 2011 Jan; 88(1-2):31-8. PubMed ID: 21034750
    [TBL] [Abstract][Full Text] [Related]  

  • 17. κ Opioid receptor activation in different brain regions differentially modulates anxiety-related behaviors in mice.
    Wang YJ; Hang A; Lu YC; Long Y; Zan GY; Li XP; Wang Q; Zhao ZX; He L; Chi ZQ; Liu JG
    Neuropharmacology; 2016 Nov; 110(Pt A):92-101. PubMed ID: 27106167
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Phosphoproteomic approach for agonist-specific signaling in mouse brains: mTOR pathway is involved in κ opioid aversion.
    Liu JJ; Chiu YT; DiMattio KM; Chen C; Huang P; Gentile TA; Muschamp JW; Cowan A; Mann M; Liu-Chen LY
    Neuropsychopharmacology; 2019 Apr; 44(5):939-949. PubMed ID: 30082888
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A G protein-coupled receptor (GPCR) in red: live cell imaging of the kappa opioid receptor-tdTomato fusion protein (KOPR-tdT) in neuronal cells.
    Huang P; Chiu YT; Chen C; Wang Y; Liu-Chen LY
    J Pharmacol Toxicol Methods; 2013; 68(3):340-5. PubMed ID: 23856011
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Long-term voluntary access to running wheels decreases kappa-opioid antinociception.
    D'Anci KE; Gerstein AV; Kanarek RB
    Pharmacol Biochem Behav; 2000 Jun; 66(2):343-6. PubMed ID: 10880688
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.